Search results
Results From The WOW.Com Content Network
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. The company went public in 1973.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The company was founded in 1995 by brothers Shivinder Mohan Singh and Malvinder Mohan Singh as Specialty Ranbaxy Limited (SRL), a 50:50 joint venture between Ranbaxy Laboratories and US-based Specialty Laboratories. [5] [6] It became the first pathology company in India to receive accreditation from National Accreditation Board. [7]
For premium support please call: 800-290-4726 more ways to reach us
Olmesartan and Sevikar HCT combined is marketed worldwide by Daiichi Sankyo, in India by Abbott Healthcare Pvt. Ltd. under the trade name WinBP, by Zydus Cadila under the trade name Olmy, by Ranbaxy Laboratories Ltd. under the trade name Olvance, Olsar by Unichem Laboratories and in Canada by Schering-Plough as Olmetec.
Volini is a brand of pain relief medical spray and cream manufactured, marketed and sold by Sun Pharma in India. [1] [2] The product was created by Ranbaxy Laboratories, but has been owned by Sun Pharma ever since Ranbaxy was acquired by the latter in 2014. [3]
Teva also sold a further 15 marketed generics, as well as three others that were close to market, for $586 million to Impax Laboratories. [66] [67] In July, Teva sold off a further 42 products to Australian generics company, Mayne Pharma, for $652 million; the deal moved Mayne up 50 spots, into the top-25 companies of US generic companies. [68]
Arterolane, also known as OZ277 or RBx 11160, is an antimalarial compound marketed by Ranbaxy Laboratories. [1] It was discovered by US and European scientists coordinated by the Medicines for Malaria Venture (MMV). [2]